What Is BPC-157?
BPC-157 is a pentadecapeptide supplied by Peptegrity for research and educational purposes. This page provides a factual educational overview of BPC-157, including its classification, biological target, research background, terminology and published study context. It is not a product page and does not provide dosing instructions, treatment recommendations or personal-use guidance.
Type of compound
BPC-157 is a synthetic pentadecapeptide, consisting of a sequence of 15 amino acids derived from a protein naturally occurring in the human gastric juice [1]. It is frequently categorized in research as a cytoprotective peptide due to its observed stability in the gastrointestinal environment [1].
Biological target and mechanism
BPC-157 is hypothesized to modulate several molecular pathways related to tissue maintenance and angiogenesis [1]. Research suggests it may interact with growth factor signaling to influence the response of connective and musculoskeletal tissues [3, 4].
Research background
Initial investigations into BPC-157 focused on its presence in gastric juices and its potential role in systemic cytoprotection [1]. Subsequent research has expanded to examine its effects on tendon-to-bone healing and general musculoskeletal recovery processes [2, 4].
Current research and development status
BPC-157 is currently in the investigational stage and is not approved by the FDA, TGA, or any other regulatory body for human therapeutic or medical use. Scientific research is ongoing, and significant biopharmaceutical challenges, such as formulation stability and delivery, remain subjects of active study [5].
Published research context
Published studies have examined the peptide's role in gastrointestinal health [1], orthopedic healing [2, 4], and its broader potential in pain management models [3]. Current literature also highlights the translational development barriers that must be addressed to understand the peptide's full pharmacodynamics [5].
Relevant terminology
A pentadecapeptide refers to a chain composed of fifteen amino acids. Cytoprotection describes the process by which chemical compounds provide protection to cells or tissues from damaging agents, a key area of study for BPC-157 [1].
Storage and handling terminology
Peptides like BPC-157 are typically stored in lyophilized (freeze-dried) form at sub-zero temperatures, such as -20°C or -80°C, to maintain structural integrity. They are handled under strict laboratory conditions to prevent degradation and ensure the purity of the research material [5].
Testing and Certificate of Analysis (COA)
A Certificate of Analysis (COA) is a document issued by quality control laboratories that confirms the purity, identity, and safety profile of a chemical compound. Researchers should verify that BPC-157 has been tested using high-performance liquid chromatography (HPLC) and mass spectrometry to ensure the compound matches the requested specifications [5].
Regulatory status
BPC-157 is strictly classified as a research chemical intended for in vitro or animal laboratory research purposes. It is not approved for clinical trials, human consumption, or any medical treatment, and its possession or use is restricted to certified research facilities.
This page is for research and educational purposes only. It is not intended to provide medical advice, dosing instructions, or treatment recommendations, and does not represent any product as approved to diagnose, treat, cure or prevent any disease. Compounds described here may be investigational or unapproved medicines; regulatory status is summarised for information only.
Frequently asked questions
What is BPC-157?
BPC-157 is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice, currently used as a subject in various biomedical research studies [1].
What is the primary regulatory status of BPC-157?
BPC-157 is an investigational compound that has not been approved for human use by any regulatory health authority, such as the FDA or TGA, and is restricted to research applications.
How is the purity of BPC-157 verified for laboratory use?
Purity is typically verified by a Certificate of Analysis (COA) which outlines the results of high-performance liquid chromatography (HPLC) and mass spectrometry testing performed on the specific batch of the peptide [5].
In what areas of research is BPC-157 currently being studied?
Research into BPC-157 spans multiple domains, including gastrointestinal cytoprotection, musculoskeletal tissue repair, and orthopedic recovery mechanisms [1, 2, 4].
How should BPC-157 be stored in a laboratory setting?
BPC-157 should be stored in a lyophilized state at low temperatures, generally -20°C or colder, to maintain peptide stability and prevent degradation over time [5].
References
- 1.Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tractPubMed
- 2.Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainPubMed
- 3.From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain ManagementPubMed
- 4.Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewPubMed
- 5.BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development BarriersPubMed
